View Older Stories View More Recent Stories

Nov 14, 2022 06:00AM Lumos Pharma Announces Encouraging Interim Results from Two Phase 2 Trials Evaluating Oral LUM-201 for Moderate Pediatric Growth Hormone Deficiency
Nov 14, 2022 06:00AM Lumos Pharma Announces Encouraging Interim Results from Two Phase 2 Trials Evaluating Oral LUM-201 for Moderate Pediatric Growth Hormone Deficiency
Nov 11, 2022 08:00AM Endologix Announces 12-Month Results of DETOUR-2 Trial at 2022 VIVA Late-Breaking Clinical Trial Session
Nov 10, 2022 07:00AM Larimar Therapeutics Reports Third Quarter 2022 Operating and Financial Results
Nov 9, 2022 04:05PM The Oncology Institute Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Guidance
Nov 9, 2022 04:05PM The Oncology Institute Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Guidance
Nov 9, 2022 07:00AM Multi-omics Startup Pleno Inc. Continues to Strengthen its Board of Directors
Nov 8, 2022 04:04PM ARS Pharmaceuticals (SPRY) Closes Merger with Silverback Therapeutics (SBTX)
Nov 8, 2022 04:02PM ARS Pharmaceuticals Closes Merger with Silverback Therapeutics
Nov 8, 2022 04:02PM ARS Pharmaceuticals Closes Merger with Silverback Therapeutics
Nov 7, 2022 05:28PM Form SC 13D/A CareMax, Inc. Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
Nov 4, 2022 08:01AM Rain Therapeutics (RAIN) Prices 6.86M Share Offering at $5.83/sh
Nov 4, 2022 08:00AM Rain Therapeutics Announces $50 Million Registered Offering of Common Stock
Nov 3, 2022 01:00PM Endologix Reports Five-Year Data of the LEOPARD Trial at 2022 Vascular InterVentional Advances (VIVA) Conference
Nov 3, 2022 07:31AM Abeona Therapeutics (ABEO) Prices 7.6M Share Private Placement at $4.6/sh
Nov 3, 2022 07:31AM Abeona Therapeutics Announces $35 Million Private Placement Financing
Nov 3, 2022 07:31AM Abeona Therapeutics Announces $35 Million Private Placement Financing
Oct 31, 2022 09:30AM Deerfield Management and BioSymetrics partner to discover and develop novel therapeutics
Oct 26, 2022 11:00AM Element Science Appoints Trish Howell as Chief Operating Officer
Oct 25, 2022 08:00AM Adaptive Phage Therapeutics Appoints Edward Fang as Chief Medical Officer
Oct 25, 2022 08:00AM Cosylab and Deerfield Management seek to increase awareness around designing, financing, and operating a Boron Neutron Capture Therapy (BNCT) center
Oct 25, 2022 07:00AM COTA Announces New Financing from Deerfield Management and Prior Investors To Accelerate Cancer Research and Treatment Innovation
Oct 20, 2022 08:00AM ELEVATE IDE Study highlights the Safety and Effectiveness of the ALTO® Abdominal Stent Graft System in One-year Results; Data to Be Presented at 2022 VEITHsymposium
Oct 18, 2022 10:34AM QUARTET HEALTH ADDS FIVE INDUSTRY LEADERS TO ITS GROWING EXECUTIVE TEAM
Oct 13, 2022 12:40PM Advancium Health Network, Launched by Deerfield Management, Receives $30M from Maxine and Stuart Frankel Foundation
Oct 12, 2022 08:48AM Sientra (SIEN) Reports Prelim. Q3 Revenue About In-Line with Consensus
Oct 12, 2022 08:45AM Sientra Announces Preliminary Unaudited Third Quarter Financial Results and Signing of Senior Secured Loan Facilities With Deerfield Management
Oct 12, 2022 07:00AM Multi-omics Startup Pleno Inc. Announces $40 Million in Series A Funding Led by Deerfield Management with Participation by Foresite Capital
Oct 10, 2022 08:02AM Dracen Pharmaceuticals announces publication in Molecular Cancer Therapeutics
Oct 10, 2022 08:00AM  Endologix Submits Premarket Approval (PMA) Application to FDA for the DETOURTM System.
Oct 5, 2022 07:30AM Cure® Names Seema Kumar Chief Executive Officer
Oct 4, 2022 08:29AM Adaptive Phage Therapeutics Awarded Additional $5 Million from U.S. Defense Health Agency to Support Diabetic Foot Osteomyelitis Clinical Trial
Sep 26, 2022 04:05PM Lumos Pharma to Participate in the Cantor Neurology & Psychiatry Conference
Sep 26, 2022 04:05PM Lumos Pharma to Participate in the Cantor Neurology & Psychiatry Conference
Sep 23, 2022 06:00AM AlivaMab Discovery Services Reappoints Dr. Larry Green as Chief Executive Officer
Sep 22, 2022 08:00AM Quartet Health Adds National Clinical Leaders to its Executive Team to Expand the Company's Commitment to Quality Mental Health Care
Sep 20, 2022 08:32PM Form 4 Larimar Therapeutics, For: Sep 16 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
Sep 19, 2022 01:07PM Moffitt Cancer Center and Deerfield Management Launch Bayfield Therapeutics
Sep 16, 2022 01:00PM Larimar Therapeutics Announces Closing of Underwritten Offering and Full Exercise of Option to Purchase Additional Shares
Sep 14, 2022 07:04AM Larimar Therapeutics (LRMR) Announces $70 Million Underwritten Offering of Common Stock
Sep 14, 2022 07:04AM Larimar Therapeutics Announces $70 Million Underwritten Offering
Sep 8, 2022 10:03AM Innervace Secures Up to $40 Million to Advance Novel Regenerative Medicine Platform for Neurological Disorders
Sep 8, 2022 08:05AM BIDMC and Deerfield Management Announce Research Collaboration to Accelerate the Creation and Development of Therapeutics
Sep 7, 2022 12:00PM Neomorph, Inc. Announces Appointment of Chief Financial Officer
Sep 7, 2022 12:00PM Neomorph, Inc. Announces Appointment of Chief Financial Officer
Sep 7, 2022 09:57AM SpringWorks Therapeutics (SWTX) Announces $225 Million Private Placement Financing
Sep 7, 2022 09:56AM SpringWorks Therapeutics Announces $225 Million Private Placement Financing
Sep 7, 2022 09:56AM SpringWorks Therapeutics Announces $225 Million Private Placement Financing
Sep 7, 2022 09:05AM Medical Microinstruments Introduces Even Smaller Robotic Instruments to Address Complex Supermicrosurgery
Aug 31, 2022 09:00AM Lumos Pharma to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
View More Recent Stories View Older Stories